Metoprolol Succinate is a selective beta-1 adrenergic receptor blocker primarily used in the management of cardiovascular conditions. It is the extended-release formulation of metoprolol, offering once-daily dosing for consistent therapeutic effects.
Mechanism of Action:
Administer orally, once daily. Individualize dose based on clinical response.